Literature DB >> 1449969

The contribution made by cell death and oxygenation to 31P MRS observations of tumour energy metabolism.

G M Tozer1, J R Griffiths.   

Abstract

This review discusses the relationship between tumour oxygenation status, tumour cell death and the 31P MRS parameters associated with cellular energy metabolism (phosphocreatine, nucleoside triphosphates and Pi). The presence of cells dying by apoptosis, and during mitosis would be unlikely to affect the 31P spectrum directly since they represent only a small fraction of tumour cells and remain energized until phagocytosed. Histologically necrotic cells also probably contribute nothing to the 31P spectrum. Instead, the spectrum appears to reflect the degree of hypoxia of the remaining viable cells, and the metabolic alterations required to sustain ATP synthesis as the oxygen supply diminishes. The biochemical theory developed to account for the 31P spectra of acutely hypoxic tissues does not apply to chronically hypoxic tumours. The concentrations of free ADP and Pi have major roles in the control of oxidative phosphorylation and glycolysis, as in normal tissues, but the precise relationships are still obscure. Cell-killing following therapy may indirectly affect 31P MRS parameters via changes in oxygen concentration brought about by an improvement in tumour blood flow and alterations in oxygen consumption rates and diffusion distances.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1449969     DOI: 10.1002/nbm.1940050515

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  15 in total

Review 1.  Magnetic resonance spectroscopy and imaging methods for measuring tumour and tissue oxygenation.

Authors:  C L McCoy; D J McIntyre; S P Robinson; E O Aboagye; J R Griffiths
Journal:  Br J Cancer Suppl       Date:  1996-07

Review 2.  Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancer.

Authors:  Kristine Glunde; Dmitri Artemov; Marie-France Penet; Michael A Jacobs; Zaver M Bhujwalla
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

3.  Induction of apoptosis in oxygen-deprived cultures of hybridoma cells.

Authors:  S Mercille; B Massie
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

Review 4.  Metabolic tumor imaging using magnetic resonance spectroscopy.

Authors:  Kristine Glunde; Zaver M Bhujwalla
Journal:  Semin Oncol       Date:  2011-02       Impact factor: 4.929

Review 5.  In Vivo Molecular Electron Paramagnetic Resonance-Based Spectroscopy and Imaging of Tumor Microenvironment and Redox Using Functional Paramagnetic Probes.

Authors:  Valery V Khramtsov
Journal:  Antioxid Redox Signal       Date:  2017-12-20       Impact factor: 8.401

6.  Bevacizumab impairs oxidative energy metabolism and shows antitumoral effects in recurrent glioblastomas: a 31P/1H MRSI and quantitative magnetic resonance imaging study.

Authors:  Elke Hattingen; Alina Jurcoane; Oliver Bähr; Johannes Rieger; Jörg Magerkurth; Sandra Anti; Joachim P Steinbach; Ulrich Pilatus
Journal:  Neuro Oncol       Date:  2011-09-02       Impact factor: 12.300

7.  Overexpression of dimethylarginine dimethylaminohydrolase enhances tumor hypoxia: an insight into the relationship of hypoxia and angiogenesis in vivo.

Authors:  Vassiliki Kostourou; Helen Troy; Joanne F Murray; Elizabeth R Cullis; Guy St J Whitley; John R Griffiths; Simon P Robinson
Journal:  Neoplasia       Date:  2004 Jul-Aug       Impact factor: 5.715

Review 8.  Is there a critical tissue oxygen tension for bioenergetic status and cellular pH regulation in solid tumors?

Authors:  P Vaupel
Journal:  Experientia       Date:  1996-05-15

9.  In vivo (31)P magnetic resonance spectroscopy and morphometric analysis of the perfused vascular architecture of human glioma xenografts in nude mice.

Authors:  B P van der Sanden; P F Rijken; A Heerschap; H J Bernsen; A J van der Kogel
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Magnetic resonance imaging and spectroscopy of combretastatin A4 prodrug-induced disruption of tumour perfusion and energetic status.

Authors:  D A Beauregard; P E Thelwall; D J Chaplin; S A Hill; G E Adams; K M Brindle
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.